Cue Biopharma, Inc. ( CUE) - Stock Earnings
CUE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -8.5 million USD | 3.0 million USD |
| 2025Q3 | -7.4 million USD | 2.1 million USD |
| 2025Q4 | 1.6 million USD | 21.9 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
CUE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.7 million USD | 5.5 million USD |
| 2024 | -40.7 million USD | 9.3 million USD |
| 2025 | -26.6 million USD | 27.5 million USD |
| 2026 Est. | — | — |
CUE
Price: $28.46
52 week price:
Earnings Per Share: -8.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 255300
Market Capitalization: 67.5 million